BTG3 and depressive symptom measurement: We also aimed to investigate if JIA individuals are diagnosed with depression and anxiety at an earlier age as compared to sex- and age-matched references without JIA, and if the risk of depression and anxiety differed between the defined groups of JIA patients; ANA-positive disease with early onset, and DMARD treated.